We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ChemRar

News List

ChemRar’s Avifavir demonstrates effectiveness against SARS-CoV-2 variants Pharmaceutical-Technology
December 29, 2021
Russia-based ChemRar Group has reported that its drug, Avifavir (favipiravir), demonstrated effectiveness against several SARS-CoV-2 variants, including Delta and Omicron.
RDIF and ChemRar agree to supply Avifavir to 17 countries pharmaceutical-technology
September 27, 2020
The Russian Direct Investment Fund (RDIF) and ChemRar Group will be supplying a Covid-19 drug, Avifavir, to 17 countries.
Russia’s RDIF, ChemRar to boost production of Avifavir for Covid-19 pharmaceutical-technology
July 06, 2020
A joint venture established by the Russian Direct Investment Fund (RDIF) and ChemRar Group is set to boost production of Avifavir, which secured temporary approval from the Russian government to treat Covid-19.